Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
NCB Financial Group $225 million senior secured notes offering
The high-yield notes are due 2030
Ambiq Micro $110.4 million IPO
The shares are listed on the New York Stock Exchange
Synchrony Financial $1 billion senior notes offering
The investment-grade notes are due 2029 and 2036
Macy’s $500 million senior notes offering and $250 million tender offers
The high-yield notes are due 2033
Bank of America $2.5 billion preferred stock offering
The company issued depositary shares representing interests in fixed-rate reset non-cumulative preferred stock
Verisk $2.35 billion acquisition of AccuLynx
We are advising Verisk on the transaction
Strategy $2.5 billion stretch preferred stock IPO
This represents the largest IPO year to date in 2025 across all U.S. preferred and common equity offerings
Adecoagro $500 million senior notes offering and cash tender offer
We advised Adecoagro on the transactions
Pagaya Technologies debut $500 million senior notes offering
We advised Pagaya on its debut high-yield notes offering
MARA Holdings $950 million convertible notes offering
The 0% convertible senior notes are due 2032